Brambati B, Simoni G, Danesino C, Oldrini A, Ferrazzi E, Romitti L, Terzoli G, Rossella F, Ferrari M, Fraccaro M
J Med Genet. 1985 Apr;22(2):92-9. doi: 10.1136/jmg.22.2.92.
Chromosome and enzyme determinations were performed in 250 pregnancies between the 7th and the 12th week of gestation. The majority of the tests were performed for risk of chromosomal abnormalities and 75% of the women were 35 years old or more. We describe a chorionic villi sampling (CVS) technique which proved to be highly efficient, with a diagnostic success rate of 97.7%. In the light of our experience we suggest that CVS is best performed between the 9th and 10th weeks of pregnancy. The average weight of the aspirated specimen was 20 mg with a lower limit of 5 mg which proved sufficient for diagnostic purposes. No major maternal complications were encountered and the slight bleeding observed in 14% of the cases during the days following the CVS should be considered a harmless effect of the aspiration technique. The proportion of fetal losses may lie between 4 and 7%. Paediatric monitoring of the 93 infants born so far and ultrasound examination of the pregnancies still in progress at the time of writing did not reveal any negative effect of CVS. Fetal-maternal transfusion and intrauterine infection are problems which need further basic investigations.
对250例妊娠7至12周的孕妇进行了染色体和酶的检测。大多数检测是针对染色体异常风险进行的,75%的女性年龄在35岁及以上。我们描述了一种绒毛取样(CVS)技术,该技术被证明是高效的,诊断成功率为97.7%。根据我们的经验,我们建议CVS最好在妊娠第9至10周进行。吸出标本的平均重量为20毫克,下限为5毫克,这已证明足以用于诊断目的。未遇到重大的母体并发症,在CVS后的几天内,14%的病例观察到的轻微出血应被视为吸取技术的无害影响。胎儿丢失率可能在4%至7%之间。对目前已出生的93名婴儿的儿科监测以及在撰写本文时仍在进行的妊娠的超声检查未发现CVS有任何负面影响。胎儿-母体输血和宫内感染是需要进一步基础研究的问题。